Investor Relations Investor Relations Latest News Jun 14, 2022 InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditions Jun 09, 2022 InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector Jun 06, 2022 InMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules Jun 02, 2022 InMed Pharmaceuticals Announces $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules btn News See All News Latest Presentation Corporate Presentation - April 2022 Corporate Presentation - April 2022 8 MB More Presentations Latest Events May 23 - May 26, 2022 H.C. Wainwright Global Investment Conference May 11, 2022 Canaccord Genuity’s 6th Annual Global Cannabis Conference April 20 - April 21, 2022 Benzinga Spring 2022 Cannabis Capital Conference btn Events See All Events Videos More Videos btn Stock See All Stock Analyst Coverage Scott R. Henry CFA ROTH Capital Partners shenry@roth.com +1 (406) 425-0563 Ken Mestemacher Edison Research Group kmestemacher@edisongroup.com +1 (646) 653-7027 Raghuram Selvaraju H.C. Wainwright rselvaraju@hcwco.com +1 (212) 916-3966 Latest Financial Reports Show all Q3 2022 Quarterly Press Release 129.7 KB 10-Q Q1 2021 2021 Annual Report 2 MB Form of Proxy - for Registered Shareholders 70.9 KB Notice and Access Notification - Internet Availability 166.4 KB Notice of Meeting and Information Circular 355.5 KB Notice of Meeting 77 KB Voting Instruction Form - for non-Registered Shareholders 70.8 KB btn QRs See All Reports Investor Alerts Sign up for investor alerts! Sign Up Information Request Send us a request for information Learn More
Investor Relations Latest News Jun 14, 2022 InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditions Jun 09, 2022 InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector Jun 06, 2022 InMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules Jun 02, 2022 InMed Pharmaceuticals Announces $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules btn News See All News Latest Presentation Corporate Presentation - April 2022 Corporate Presentation - April 2022 8 MB More Presentations Latest Events May 23 - May 26, 2022 H.C. Wainwright Global Investment Conference May 11, 2022 Canaccord Genuity’s 6th Annual Global Cannabis Conference April 20 - April 21, 2022 Benzinga Spring 2022 Cannabis Capital Conference btn Events See All Events Videos More Videos btn Stock See All Stock Analyst Coverage Scott R. Henry CFA ROTH Capital Partners shenry@roth.com +1 (406) 425-0563 Ken Mestemacher Edison Research Group kmestemacher@edisongroup.com +1 (646) 653-7027 Raghuram Selvaraju H.C. Wainwright rselvaraju@hcwco.com +1 (212) 916-3966 Latest Financial Reports Show all Q3 2022 Quarterly Press Release 129.7 KB 10-Q Q1 2021 2021 Annual Report 2 MB Form of Proxy - for Registered Shareholders 70.9 KB Notice and Access Notification - Internet Availability 166.4 KB Notice of Meeting and Information Circular 355.5 KB Notice of Meeting 77 KB Voting Instruction Form - for non-Registered Shareholders 70.8 KB btn QRs See All Reports